Nxera Pharma Co Eulerpool Uudised

Nxera Pharma Co Eulerpool News

Nxera Pharma Co aktsia uudised

Nxera Pharma Co jälgivad paljud ajakirjanikud ja investorid üle kogu maailma. Kõige värskemad Nxera Pharma Co uudised paneme siia kokku.

• 2. september ·

  Yahoo
  Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
• 28. august ·

  Yahoo
  Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
• 9. august ·

  Yahoo
  Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2024
• 9. juuli ·

  Yahoo
  Nxera Pharma Webinar Presentation for Q2 FY2024 Financial Results
• 9. juuli ·

  SeekingAlpha
  Neurocrine's Pipeline, Including Crinecerfont's Priority Review, Drives Long-Term Growth
• 27. juuni ·

  Yahoo
  Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
• 18. juuni ·

  Yahoo
  Nxera Pharma Publishes its Annual and ESG Reports for the Year ended 31 December 2023
• 30. mai ·

  Yahoo
  Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
• 30. mai ·

  Yahoo
  Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
• 9. mai ·

  Yahoo
  Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults